Caplin Point Laboratories will acquire 100% of Triwin Pharma SAB DE C.V., a Mexican pharmaceutical marketing and distribution company, via its Hong Kong subsidiary. This move enables participation in Mexican government tenders and expands their LATAM presence.

• Strategic entry into the Mexican market.
• Supports the stock and sales distribution model.
• Leverages successful LATAM strategies.